<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: Colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> is the most common gastrointestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>The survival of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has not varied appreciably in recent years </plain></SENT>
<SENT sid="2" pm="."><plain>The knowledge that genetic factors could play a role in the etiology and prognosis of patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has opened up new lines of research </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of the study was to evaluate a group of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and the possible influence on the prognosis of immunohistochemical hMLH1, hMSH2 and CD34 expression </plain></SENT>
<SENT sid="4" pm="."><plain>MATERIAL AND METHODS: 37 cases of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were included in this study </plain></SENT>
<SENT sid="5" pm="."><plain>HMLH1, hMSH2 and CD34 protein expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue sections was determined using immunohistochemical staining with specific monoclonal antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>A total of 37 tumors were analyzed for histopathology </plain></SENT>
<SENT sid="7" pm="."><plain>The immunoexpression status of MMR genes was correlated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage, location, histology, gender and CD34 immunoexpression </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Of the 37 cases immunohistochemical analysis showed 13 (35.1%) had loss of expression of hMLH1, 5 (13.5%) had loss of expression of hMSH2, and five cases had loss of expression of both proteins </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate analysis showed that right side dominance (p&lt;0.05) poorly differentiated and male (p&lt;0.05) were associated with loss of expression of hMLH1 or hMSH2 </plain></SENT>
<SENT sid="10" pm="."><plain>Loss of expression of hMLH1 or hMSH2 correlated with low CD34 expression (p&gt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CD34 immunoexpression was higher in the left side <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location, stage D Dukes'a (p&lt;0.05) and G2 (p&lt;0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: These results confirm that <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal MMR-defective <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> display certain specific morphological characteristics </plain></SENT>
<SENT sid="13" pm="."><plain>However, these pathological features are not sufficiently predictive and immunohistochemistry is needed to identify such <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> accurately </plain></SENT>
<SENT sid="14" pm="."><plain>The researches on <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells can be used as prognostic factors for the patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>